HUTCHMED Switches Clinical Strategy To Rely On Partnerships For Late-Stage Assets In US

 
• By Dexter Jie Yan
  
Asia strategy
HUTCHMED seeks partnerships to advance three molecules into the clinic outside of China. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia